Global Stock News

What to watch after Friday’s close as FDA review scrutiny and Novo’s pill data hit

What to watch after Friday’s close as FDA review scrutiny and Novo’s pill data hit

New York, January 18, 2026, 10:06 EST — Market closed

  • On Friday, Eli Lilly shares ended the day at $1,038.40, marking a 0.5% rise.
  • Attention is now on when fast FDA reviews will land and how solid they’ll be legally, alongside what early prescription numbers reveal about the coming obesity-drug competition.
  • The U.S. markets will be closed Monday. Trading resumes Tuesday, with Lilly’s earnings call for Feb. 4 coming up next.

Eli Lilly shares ended Friday at $1,038.40, rising 0.5% after fluctuating between $1,019 and $1,049.83 during the session. With U.S. markets shut for the weekend, traders are left to digest regulatory and competitive developments ahead of Monday’s open.

Why it matters now: Lilly’s…

Source link

Share this article

Scroll to Top